Neurocognitive Function and Progression in Patients With Brain Metastases Treated With Whole-Brain Radiation and Motexafin Gadolinium: Results of a Randomized Phase III TrialChristina A. Meyers, Markus F. Renschler, Ross Siemers et al.|Journal of Clinical Oncology|2003Cited by 587
Symptom Improvement in Lung Cancer Patients Treated With Erlotinib: Quality of Life Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21Andrea Bezjak, Frances A. Shepherd, Dongsheng Tu et al.|Journal of Clinical Oncology|2006Cited by 295
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statementMatthias Gückenberger, David A. Palma, Claus Belka et al.|Radiotherapy and Oncology|2020Cited by 227
Logistics of collecting patient-reported outcomes (PROs) in clinical practice: an overview and practical examplesMatthias Rose, Andrea Bezjak|Quality of Life Research|2009Cited by 157
Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and EfficacySally C. M. Lau, Adrian G. Sacher, Malcolm Ryan et al.|JTO Clinical and Research Reports|2021Cited by 11